Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.06 from other evidence | 0.00 |
| cell type Human Protein Atlas | group enriched outside the brain (corticotrophs) | 0.10 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 105 Parkinson's papers of 320 | 0.39 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 4260
Sealed predictions
- LMX1A in dopamine neurons, braak-0.58 (p 0.103) → +0.43 (p 0.244)receipt 4266
Swarm cases
receipt 4266: LMX1A in dopamine neurons, braak
- power
- full sample +0.20 (p 0.434, n 18), 95% CI -0.30 to +0.61. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.22 (p 0.389, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.01 (p 0.983, n 18). could be the mix.
- skeptic
- leave-one-out range +0.10 to +0.35, sign flips 0; without severely affected donors +0.20 (p 0.434, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LMX1A in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts